Background and Purpose:
The Technology Development Accelerator Fund was established by the
Office of Technology Development under the auspices of the Office of the
Provost in order to help support Harvard faculty in the performance of applied
research in the Life Sciences--support that can often be difficult
to obtain from traditional funding sources and granting agencies. A
significant obstacle to the development and transfer of university
technology is the lack of funding for proof-of-concept and validation
studies, essential steps required to demonstrate commercial potential.
The Accelerator Fund is designed to overcome this barrier by providing
funding assistance to faculty in the early stages of developing and
validating nascent technologies originating in their labs. The strategic
objective of the Accelerator is to assist Harvard to license such
technologies more effectively and to expedite the transfer and public
availability of promising new technologies. With this objective in mind,
the Accelerator seeks to support innovative research aimed at extending
preliminary observations, establishing proof-of-principle, and
generating (or enhancing) intellectual property positions.
The Accelerator Fund, and the progress of funded projects, will be
managed by the Office of Technology Development (OTD), in consultation
with an external advisory committee appointed by the Provost. The
advisory committee will make all award decisions. The Accelerator Fund
has committed $1.25 million for 2009 to support investigator-initiated
projects through proof-of-principle, at which point it is hoped that
other financing alternatives (e.g., private industry and/or venture
capital) will become available. Additional funds have been committed
such that the Accelerator will be sustained for at least another three
years. The Accelerator is designed to accommodate projects of varying
magnitude, as appropriate.
The Fund has been structured as an "evergreen" fund, thus helping to
support further innovation and applied research at Harvard. To this end,
a portion of any future licensing proceeds that may be generated from
the licensing of technologies arising from, or advanced as a result of
Accelerator funding will be returned to the Accelerator Fund.
NOTE: The deadline for submission of a pre-proposal (as described
below) in academic year 2009/2010 is March 2, 2009.
I. Program Eligibility
- Who May Apply?
Anyone with rights as a principal
investigator and whose employer is Harvard University is eligible to
apply.
- Field:
The focus of the proposal must be in the Life
Sciences.
- Research Eligible for Funding:
Examples of the type of
research that would be considered eligible for funding include, but are
not limited to:
- Structure-based design and synthesis of small molecule modulators
of novel drug targets
- Testing of small molecules in cell-based and/or animal models of
disease to investigate their therapeutic relevance or demonstrate
proof-of-concept
- Medicinal chemistry on compelling hits obtained from
high-throughput screens (e.g. to define structure-activity
relationships, increase potency or optimize target selectivity,
improve metabolic stability for in vivo testing)
- Testing of monoclonal antibodies and other biologics for
diagnostic or therapeutic uses (in vivo, ex vivo)
- High-throughput screens for modulators of novel, high-value
targets with the goal of generating probes of molecular function
("tool compounds")
II. Funding Levels
Within the established budgetary parameters, projects will be funded at the level deemed necessary to
achieve the proposed research objectives. Depending on the nature of the
research and the objectives, it is anticipated that typical awards will
range between $100,000-$150,000 for a period of one year, although
exceptions may be made as appropriate.
One such exception relates to proposed optimization of small molecules
discovered via high-throughput screening - "medicinal chemistry"
projects - for which we have a new roadmap. In general these projects
will begin with a "pilot grant" of approximately $10,000 - $25,000 for a
period of three to six months. During the term of the pilot grant, the
investigator will work with the Chief Scientific Officer of the
Accelerator Fund and OTD staff to answer key questions related to
suitability of the compound(s) for full medicinal chemistry. These
questions will include:
- Have the relevant high-throughput screening "hits" have been
repurchased (or re-synthesized) and their activities confirmed by
dose-response curve in the primary screening assay?
- Have the compounds have undergone analytical testing (e.g. mass
spec, NMR) to confirm their structures?
- Has a medicinal chemistry plan been drafted which clearly
articulates the goals for the optimization and identifies key
liabilities of the molecules that need to be addressed? This plan
should identify an initial target set of analogs which can be purchased
or synthesized and tested to determine whether the project is a good
candidate for a large-scale medicinal chemistry effort.
- Is an appropriate, robust bioassay (molecular or cell-based) for
analog testing currently implemented and validated in the
investigator's lab?
In cases where the above requirements have already been met at the time
of application, a project will be considered for immediate full-scale
Accelerator funding (~$100,000-$150,000 for a period of one year).
Otherwise, if a project awarded a "pilot grant" yields favorable
results, this project will then be considered by the Accelerator
Advisory Committee for full Accelerator funding.
III. Budget and Resources
All proposals should include a
detailed budget.
- Funding will not be subject to Harvard indirect expense charges.
- Funding may only be used for research directly related to, and
budgeted under the project, and may not be used for any other purpose.
Budget items may not include PI salary, capital equipment or
travel. The research project may be structured such that some, or even
a large portion of the approved, budgeted activities will be outsourced
to one or more approved contract research organizations (CROs). OTD
will assist the PI to identify qualified CROs, and OTD will negotiate a
work-for-hire agreement on behalf of the PI.
IV. Proposal Review and Selection Process
1. Pre-proposals
Applicants should work closely with the OTD team to develop a short
pre-proposal. Only one proposal per applicant will be accepted.
Pre-proposals should be no more than 2 pages in length. In order
to identify the most promising projects, the pre-proposals will be
subject to a preliminary review and triage process by the OTD team.
Those applicants whose proposals are deemed to best satisfy the
Accelerator threshold evaluation criteria (see below) will be invited to
submit a full proposal. It is anticipated that approximately 10
applicants submitting pre-proposals will be invited to submit full
proposals.
Format for Pre-proposals: The pre-proposal should address and
contain the following:
Section 1 - Background and Significance
- Need and Significance (highlighting the novelty, risk and potential
benefits of the project).
- Briefly describe recent research directly relevant to the proposal,
including others in the field and, in particular, your own work.
Section 2 - Proposed Research Plan
- Specific Aims and Objectives - For each specific objective, provide
a rough estimate of the cost and time required for completion.
- Describe the criteria that will be used to determine if the
specific aims have been achieved.
- Total amount requested.
Section 3 - Investigator Data
- Principal Investigator(s)
- Collaborators and/or other key project participants, if any
- Identify all prior, current and/or pending sources of support to
your lab related to the proposed research project.
- P.I. curriculum vitae (in brief)
Appendix - Relevant publications/manuscripts (no more than 5)
2. Full Proposals
Full proposals must be prepared in accordance with the outline in
attached Appendix A. Such proposals should be no longer than 20
pages long. OTD will work closely with PIs to provide assistance in the
development of full proposals, in particular the establishment of sound
technical milestones and appropriate budgets. Full proposals will be
reviewed by the Accelerator Fund Advisory Committee, a small group of
external technical advisors and experts appointed by the Provost. The
Advisory Committee (in consultation with OTD) will make all award
decisions, which decisions will be final. OTD will facilitate the
implementation of Advisory Committee recommendations, as appropriate.
V. Threshold Evaluation Criteria
Selection of proposals for funding will be based on an equal weighting
of criteria related to scientific/technical merit, commercial potential,
the potential of obtaining broad, enforceable patent protection, and the
potential for technology transfer. The following factors comprise the
major threshold evaluation criteria which will be taken into
consideration as part of the proposal review process:
Scientific and Technical Merit
- Quality of the proposed research and scholarship.
- Innovation and novelty of the proposed research and/or technology
in question.
- Technical feasibility and risk of the project and/or technology in
question.
- Probability of achieving project goals within the proposed budget.
- Clarity and focus of the research objectives and proposed technical
milestones.
- Potential impact and significance of research results on human
health and public benefit.
Potential for Technology Transfer
- Probability that research results will enable and support obtaining
a strong patent position, or enhancing an existing patent position.
- Significance of market need and opportunity.
- A relatively clear and short path to a commercially viable
technology.
- Whether, and the extent to which, the technology in question offers
a competitive advantage over currently available technologies
- Probability that funding will result in significant advances
leading to additional extramural funding (from industry) and/or
technology transfer.
VI. Duration of Funding Period
Proposals will be funded for up to 12 months of effort. Extensions or
renewals for a second year may be granted, subject to demonstrated
progress, submission of a new application and approval by the
Accelerator Advisory Committee. An exception is if during this 12-month
period, funding support for the same project is secured from industry,
in which case the remaining (unused) funds provided by the Accelerator
will be returned to the Accelerator.
VII. Reporting Requirements
Progress reports will be prepared and submitted three times per year,
inclusive of a final report. The final report is due within 30 days of
the end of the grant period. The final report should specifically
address research results relative to each specific aim and a statement
of any inventions made in the course of the performance of the funded
project. Periodic financial reports will be run to verify
appropriateness of expenses to the project.
VIII. Other Requirements: Terms and Conditions of the Award
- Time and Effort: The PI will commit his/her time and effort,
as appropriate, to lead and oversee the project.
- Inventions and Intellectual Property: It is not necessary
for there to be any background or pre-existing inventions, nor that
there be any prior intellectual property, however if there is any
background intellectual property it must have been assigned to Harvard.
In the event that any new inventions are conceived or reduced to
practice in the course of performing a research project supported by an
Accelerator award, it must be disclosed to the Office of Technology
Development and, thereafter, assigned to Harvard. The PI must
report any and all inventions to OTD in advance of a public disclosure,
within 30 days of the disclosure, in order to allow OTD staff to
determine if such public disclosure contains new potentially patentable
subject matter.
- Research Plan: Any significant mid-course revisions to the
research plan will require approval by OTD and the Accelerator Advisory
Committee.
- Milestones: The applicant's proposal must comprise a
research plan that includes proposed objective technical milestones,
which need to be accepted by OTD and the Advisory Committee. The
achievement of such milestones will serve as key decision points for
the assessment of progress and the determination of continued funding.
A project may be terminated if agreed-upon technical milestones have
not been met.
- Funding Status: In the event that a proposed project should
receive funding support from industry during the interval between the
date the proposal is submitted to the Accelerator for review and the
time funding decisions are made, it will no longer be considered
eligible for Accelerator funding. Moreover, as stated above, if a
project is awarded Accelerator funding, but during the 12-month funding
period, funding support for the same project is secured from industry,
the remaining (unused) funds provided by the Accelerator will be
returned to the Accelerator.
Submission of Proposals
Pre-proposals must be received by no later than 6:00PM on March 2,
2009 in Microsoft Word (.doc) or Adobe Reader (.pdf) format.
Proposals should be submitted via e-mail to: curtis_keith@harvard.edu.
The subject line should read "Accelerator Proposal."
If you have any questions please call: (617) 496-0478.
|
Schedule and Deadlines - 2009
|
| January 26, 2009 |
RFP |
| March 2, 2009 |
Deadline to submit pre-proposals |
| March 16, 2009 |
Announce decisions/solicit full proposals |
| April 27, 2009 |
Deadline to submit full proposal |
|
= Advisory Committee Review Period and Meeting =
|
| May 28, 2009 |
Awards announced by the Provost |
Appendix A: Format for Full Proposal
Cover Page
Budget
PI Name, Department
Project Title
Section 1 - Project Summary or Abstract
- Describe the need, problem or opportunity, and significance of
the project
- Describe the potential benefits of the project
- State the research objectives, research plan and anticipated
results
Section 2 - Project Description
- Research Objectives
- describe your specific research objectives in order of priority
- for each objective, estimate the cost and time required for
completion
- identify any objectives that may require more time to complete
or are contingent upon completion of earlier stage objectives
- Research Plan and Milestones (a.) provide a brief introduction to
the area of investigation (b.) describe the experimental methods you
will utilize to achieve each objective (c.) describe the anticipated
results (d.) provide a 12 month work performance schedule or GANTT
chart (e.) proposed objective technical milestones
- III. Related Research and Research Support (a.) describe
significant recent research related to this proposal, including your
own work and others in the field.
Section 3 - Intellectual Property (if applicable)
- provide a brief description of any inventions you have already
made related to the proposed research
- provide a statement about the current status or stage of the
invention.
- describe how the proposed research will add value to and enhance
the invention's patentability and/or commercial potential and/or
importance
Section 4 - Budget and Budget Instructions (create a budget
worksheet)
Section 5 - Key Personnel & Collaborators
Brief Bios
Appendix: Manuscripts/Publications
Download PDF version